The Electronic Asthma Management System in Pharmacies

Condition(s) studied

Investigational drug(s) / intervention(s)

Pharmacy Clinical Decision Support System for Asthma Management: A pharmacy clinical decision support system that generates individualized advice for asthma patients is provided to the pharmacist/RPht/assistant/student.

Study summary

The goal of this study is to assess the effect of an electronic asthma management system in pharmacies (eAMS-Pharm) on asthma control assessment, asthma medication adjustment, asthma action plan delivery, and prompting for specialist referral in severe asthma. The study assesses the differences on pharmacy processes (affecting both the pharmacy team and patients) and pharmacy-delivered care using an interrupted time-series analysis (six-months before vs. six-months after the introduction of eAMS-Pharm in study pharmacy sites).

The eAMS-Pharm uses patient data (asthma control, asthma flare-up risk, and current medications) to provide clinical decision support to pharmacists, empowering them to bridge existing gaps between guideline-recommended asthma care and patient care received.

Eligibility

Primary outcome measure(s)

• Medication adjustments — 12 months, broken into individual time series periods
  Using pharmacist chart review, the investigators will assess the proportion and trend in patients receiving medication adjustments
• Asthma control assessment — 12 months, broken into individual time series periods
  Using pharmacist chart review, the investigators will assess the proportion and trend of patients receiving asthma control assessment by guideline criteria
• Asthma action plan creation — 12 months, broken into individual time series periods
  Using pharmacist chart review, the investigators will assess the proportion and trend of asthma action plans being created for patients

Trial sites (3)

More Unity Health Toronto trials in Canada

Other trials for the same condition